Just FYI, the Lava Software Framework that resulted from Intel's Neuromorphic Computing Lab is an open-source project with portions of the framework covered by the LGPL 3.0 and BSD 3-Clause Open Source licenses.
From the description, it is meant to be an abstraction that is platform-agnostic and should support a range of neuromorphic chips. I have not looked into its architecture, but a typical approach would be to support a modular design that would allow it to support more than just Intel's Loihi processor. This project itself still seems to be pretty fresh and the documentation (which can be found here) is still fairly incomplete.
I would imagine that if Lava becomes a more desirable platform (over Tensorflow) to develop applications for neuromorphic processors, it would not surprise me if either Brainchip enthusiasts would contribute to the project or perhaps Brainchip themselves allocate resources to contribute support for Akida and its line of neuromorphic processors.
It would definitely make for some good press too.
- Forums
- ASX - By Stock
- 2021 BRN Discussion
Just FYI, the Lava Software Framework that resulted from Intel's...
-
- There are more pages in this discussion • 7,485 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $342.8M |
Open | High | Low | Value | Volume |
17.5¢ | 18.0¢ | 17.0¢ | $737.6K | 4.203M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
69 | 1587304 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 213251 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
69 | 1587304 | 0.170 |
49 | 923903 | 0.165 |
67 | 1409816 | 0.160 |
23 | 964104 | 0.155 |
69 | 1820964 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 123251 | 3 |
0.180 | 1205075 | 25 |
0.185 | 924511 | 27 |
0.190 | 1431809 | 21 |
0.195 | 984971 | 15 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
NEWS
Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEWS
Is oil undervalued?
BRN (ASX) Chart |